Cargando…

Valuation of the EQ-5D-5L in Taiwan

OBJECTIVES: To date, a value set for the EQ-5D-5L based on the health state preferences of the general Taiwanese population has not been available. This study aimed to develop a Taiwanese value set for EQ-5D-5L to facilitate health technology assessment for medical products and services. METHODS: An...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lin, Hsiang-Wen, Li, Chia-Ing, Lin, Fang- Ju, Chang, Jen-Yu, Gau, Churn-Shiouh, Luo, Nan, Pickard, A. Simon, Ramos Goñi, Juan M., Tang, Chao-Hsiun, Hsu, Chien-Ning
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2018
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6306233/ https://www.ncbi.nlm.nih.gov/pubmed/30586400 http://dx.doi.org/10.1371/journal.pone.0209344

Ejemplares similares

The impact of the rare disease and Orphan Drug Act in Taiwan
por: Hsiang, Ning-Chun, et al.
Publicado: (2021)

Patient Involvement in the Health Technology Assessment Process in Taiwan
por: Chen, Kuei An, et al.
Publicado: (2022)

Euthanasia, religiosity and the valuation of health states: results from an Irish EQ5D5L valuation study and their implications for anchor values
por: Barry, Luke, et al.
Publicado: (2018)

Valuation and Modeling of EQ-5D-5L Health States Using a Hybrid Approach
por: Ramos-Goñi, Juan M., et al.
Publicado: (2017)

Findings from a Roundtable Discussion with US Stakeholders on Valuation of the EQ-5D-Y-3L
por: Nazari, Jonathan L., et al.
Publicado: (2022)

The EQ-5D-5L Valuation Study in Egypt
por: Al Shabasy, Sahar, et al.
Publicado: (2021)

Valuation of the EQ-5D-3L in Russia
por: Omelyanovskiy, Vitaly, et al.
Publicado: (2021)

Comparison of online and face-to-face valuation of the EQ-5D-5L using composite time trade-off
por: Jiang, Ruixuan, et al.
Publicado: (2020)

Improving valuation sampling of EQ-5D health states
por: Bagust, Adrian
Publicado: (2013)

The development of new research methods for the valuation of EQ-5D-5L
por: Devlin, Nancy J., et al.
Publicado: (2013)

RETRACTED ARTICLE: The EQ-5D-5L Valuation Study in Egypt
por: Al Shabasy, Sahar A., et al.
Publicado: (2021)

Retraction Note to: The EQ-5D-5L Valuation Study in Egypt
por: Al Shabasy, Sahar A., et al.
Publicado: (2021)

COVID-19 and EQ-5D-5L health state valuation
por: Webb, Edward J. D., et al.
Publicado: (2023)

Mapping and direct valuation: do they give equivalent EQ-5D-5L index scores?
por: Luo, Nan, et al.
Publicado: (2015)

Canadian Valuation of EQ-5D Health States: Preliminary Value Set and Considerations for Future Valuation Studies
por: Bansback, Nick, et al.
Publicado: (2012)

Valuation of EQ-5D-5L Health States in Poland: the First EQ-VT-Based Study in Central and Eastern Europe
por: Golicki, Dominik, et al.
Publicado: (2019)

Epidemiology, clinical profile and treatment patterns of venous thromboembolism in cancer patients in Taiwan: a population-based study
por: Chew, Tan-Wei, et al.
Publicado: (2015)

Comparing responsiveness of the EQ-5D-5L, EQ-5D-3L and EQ VAS in stroke patients
por: Golicki, Dominik, et al.
Publicado: (2014)

Logical inconsistencies in time trade-off valuation of EQ-5D-5L health states: Whose fault is it?
por: Yang, Zhihao, et al.
Publicado: (2017)

Validation of the EQ-5D in Taiwan using item response theory
por: Liu, Tzu-Hung, et al.
Publicado: (2021)

Valuation of the EQ-5D-5L with composite time trade-off for the German population – an exploratory study
por: Ludwig, Kristina, et al.
Publicado: (2017)

Determinants of Health Preferences Using Data from the Egyptian EQ-5D-5L Valuation Study
por: Al Shabasy, Sahar, et al.
Publicado: (2022)

Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
por: Lipman, Stefan A., et al.
Publicado: (2022)

EQ-5D-Y-3L Value Sets, Valuation Methods and Conceptual Questions
por: Devlin, Nancy, et al.
Publicado: (2022)

A French Value Set for the EQ-5D-5L
por: Andrade, Luiz Flavio, et al.
Publicado: (2020)

Comparisons of EQ-5D-Y and PedsQL in pediatric patients with mild-to-moderate chronic kidney disease in longitudinal analyses
por: Hsu, Chien-Ning, et al.
Publicado: (2023)

Validity of EQ-5D-5L in stroke
por: Golicki, Dominik, et al.
Publicado: (2014)

Employing quality control and feedback to the EQ-5D-5L valuation protocol to improve the quality of data collection
por: Purba, Fredrick Dermawan, et al.
Publicado: (2016)

Preference heterogeneity in health valuation: a latent class analysis of the Peru EQ-5D-5L values
por: Karim, Suzana, et al.
Publicado: (2023)

Elicitation of Norwegian EQ-5D-5L values for hypothetical and experience-based health states based on the EuroQol Valuation Technology (EQ-VT) protocol
por: Hansen, Tonya Moen, et al.
Publicado: (2020)

Age dependency of EQ-5D-Youth health states valuations on a visual analogue scale
por: Retra, Jim G. A., et al.
Publicado: (2020)

Correction to: Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology
por: Lipman, Stefan A., et al.
Publicado: (2022)

Duration of dual antiplatelet therapy following percutaneous coronary intervention on re-hospitalization for acute coronary syndrome
por: Chen, Shih-Chin, et al.
Publicado: (2014)

Exploring the Comparability of Face-to-Face Versus Video Conference-Based Composite Time Trade-Off Interviews: Insights from EQ-5D-Y-3L Valuation Studies in Belgium and Spain
por: Estévez-Carrillo, Anabel, et al.
Publicado: (2022)

EQ-5D-5L measurement properties are superior to EQ-5D-3L across the continuum of health using US value sets
por: Jiang, Ruixuan, et al.
Publicado: (2022)

The Indonesian EQ-5D-5L Value Set
por: Purba, Fredrick Dermawan, et al.
Publicado: (2017)

Regulatory considerations for generic products of non-biological complex drugs
por: Liu, Yu-Hsuan, et al.
Publicado: (2023)

Self vs. other, child vs. adult. An experimental comparison of valuation perspectives for valuation of EQ-5D-Y-3L health states
por: Lipman, S. A., et al.
Publicado: (2021)

Exploring the importance of controlling heteroskedasticity and heterogeneity in health valuation: a case study on Dutch EQ-5D-5L
por: Karim, Suzana, et al.
Publicado: (2022)

An EQ-5D-Y-3L Value Set for Belgium
por: Dewilde, Sarah, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_fgjn9qjplur85f3phjl0mjl0ef